Provenance Record

Well-structured News piece (676 words, within the 400-1200 News range). Clear Overview / What We Know / What We Don't Know / Analysis arc. Technical detail on the workbench (curated skills, connectors, reviewer agent, compute management) is accurate and appropriately attributed. Every capability claim is hedged with 'the company says' / 'according to Anthropic' rather than stated as objective fact.

All 5 source snapshots read from disk (gzipped) and verified against the claims. source-0.html.gz (anthropic.com, 200): CONFIRMS the Jun 30 2026 launch, 'AI workbench for scientists' title, beta on macOS/Linux for Pro/Max/Team/Enterprise, 'over 60 curated skills and connectors pre-configured for genomics, single-cell, proteomics, structural biology, cheminformatics', reviewer agent that 'checks citations and calculations, flagging and correcting errors', the 50 AI-for-Science projects / up to $30,000 credits / applications through July 15 / notifications by July 31, and named partners NVIDIA BioNeMo Agent Toolkit, Modal, Manifold Bio, Allen Institute. source-1.html.gz (healthcaremea.com, 200): CONFIRMS the neglected-disease internal drug program ('The company has established an internal research programme focused on developing treatments for neglected diseases'), the CRISPR/single-cell/3D protein/chemistry drawings/genome browser tracks task list, PubMed/Jupyter/R integrations, and the BMS May 2026 strategic agreement to deploy Claude across more than 30,000 employees. source-2.html.gz (pharmaphorum.com, 200): CONFIRMS 'first product specifically designed by Anthropic for use by life science researchers', the Basecamp Research EDEN 'world's largest biological dataset' connector, and the Stephen Francis title and verbatim quote 'After months of beta testing Claude Science, I'm convinced. This tool is going to accelerate scientific discovery in a big way.' source-3.html.gz (statnews.com, 200): CONFIRMS the June 30 2026 date, the 'optimizes the company's large language model for use in scientific laboratories and, especially, within the research operations of pharmaceutical companies' framing, and the verbatim Amodei quote 'a general purpose technology that helps us to make sense of that complexity, in its full complexity, better.' STAT also independently corroborates the drug-program angle ('AI company Anthropic announces it will begin developing drugs of its own'). source-4.html.gz (technologyreview.com, 200 — OFF ALLOWLIST): CONFIRMS the verbatim Eric Kauderer-Abrams quote, the 'same way that Claude Code supports software engineering' framing, and the Alexander Tarashansky phenylketonuria demonstration. All quotes reproduced verbatim; no hallucinated quotes or misattributions found across any source.

Every specific (June 30 2026 launch, 60+ skills, $30,000 credits, July 15 / July 31 dates, 30,000 BMS employees, named partners, EDEN, phenylketonuria) traces to a cited source. Headline, summary and Overview lead rest entirely on allowlisted sources (Anthropic, STAT, HealthCare Middle East & Africa). No load-bearing claim depends on the off-allowlist MIT Technology Review source, which supplies only secondary color (the Kauderer-Abrams quote, the Claude-Code analogy phrasing, and the phenylketonuria demo).

APPROVE_WITH_CORRECTIONS. Substantively strong, well-balanced News piece; every claim, specific, and quote verified against its source snapshot. The sole issue is a single off-allowlist source used for non-load-bearing color, honestly summarizable in a clarification note that publishes alongside the article.